Logo smallSearch
Tydzień Pacjencki

Patients with multiple myeloma are still waiting for changes

MedExpress Team


Published May 11, 2022 10:43

Patients with multiple myeloma are still waiting for changes - Header image
Fot. Getty Images/iStockphoto
Hematooncology deals with the treatment of neoplastic diseases related to blood and the production of its components - white cells, red cells, platelets and plasma. Each year in Poland, about 9,000 are diagnosed. children and adults with these tumors. On May 28, we will celebrate the World Blood Cancer Day. Today we remind you of the urgent needs of patients struggling with these diseases.

Multiple myeloma is a B-cell neoplasm that is terminally differentiated. It is characterized by the uncontrolled growth of abnormal plasmocytes, i.e. cells whose primary task is to produce antibodies.

The exact number of multiple myeloma diagnosed in Poland is difficult to establish. Every year, more than 2,000 people learn about the disease. The first disturbing symptom of the disease in terms of diagnostic tests should be a high ESR result with a simultaneous low CRP result. A complete cure for multiple myeloma is virtually impossible. Even if the 1st line of treatment proves to be very effective, sooner or later it will relapse or progress. After each of them, the respo...

Content locked

To gain access to the complete English section of the, kindly reach out to us at [email protected].

If you already have an account, please log in

Read also